CDKN2B-AS1 and gastric cancer: ANRIL is expressed highly in gastric cancers, and higher levels of ANRIL promote proliferation of gastric cancer cells, where it inhibits apoptosis by epigenetic silencing of miR‐99a and miR‐449a transcription 95.